Tubulis raised €128m in a Series B extension backed by EQT Life Sciences and Nextech Invest

Biotech Health services

Investments

03 March 2024

Tubulis (company)

Biotech Health services

Total investments received (USD): N/A

Round value (USD): 138.11m

Round investors: Andera Partners Bayern Kapital BioMedPartners Coparion EQT Partners Fundplus High-Tech Gründerfonds OCCIDENT Seventure Partners Evotec AG Deep Track Capital Nextech Invest Frazier Life Sciences

Company: Tubulis

Industry: Biotech Health services

Related deals

CatalYm raised $150m in Series D funding co-led by Canaan Partners and Bioqube Ventures

Biotech Health services Manufacturing

Investments 04 July 2024

Isotopen Technologien München raised €188m in a round led by Temasek, joined by BlackRock, Qatar Investment Authority, Athos, and Carbyne.

Biotech Health services Pharma

Investments 01 June 2024

Cardior Pharmaceuticals was acquired by Novo Nordisk for 1.025 billion Euro

Biotech Health services Pharma

Secondary 21 March 2024

Menu

Tubulis raised €128m in a Series B extension backed by EQT Life Sciences and Nextech Invest

Share:

Tubulis (company)

Related deals

CatalYm raised $150m in Series D funding co-led by Canaan Partners and Bioqube Ventures

Isotopen Technologien München raised €188m in a round led by Temasek, joined by BlackRock, Qatar Investment Authority, Athos, and Carbyne.

Cardior Pharmaceuticals was acquired by Novo Nordisk for 1.025 billion Euro

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe